3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Febrile Neutropenia
5
Neoplasms
4
Hematologic Neoplasms
3
Neutropenia
2
Urinary Bladder Neoplasms
1
Sepsis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Other Infectious Diseases
1
Leukemia, Myeloid, Acute
1
Fever
1
Emergencies
1
Interventions
Hydromorphone
2
NF protocol
1
Meropenem
1
Levofloxacin
1
Ketorolac
1
Heller Myotomy
1
Glucose
1
Fentanyl
1
Colectomy
1
Anti-Bacterial Agents
1
Amoxicillin-Potassium Clavulanate Combination
1
Acupuncture Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Emergencies
×
Meropenem
×
Clear all
NCT05393505
2022-12-06
FRANCiS-NF
The University of Hong Kong
Phase 4
Unknown
344 enrolled